CLINICAL TRIALS PROFILE FOR RESTASIS
✉ Email this page to a colleague
All Clinical Trials for restasis
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00348335 ↗ | Efficacy of Topical Cyclosporin for Ocular Rosacea | Completed | Allergan | Phase 4 | 2006-06-01 | The purpose of this study is to determine whether Restasis (topical cyclosporin) is effective in the treatment of ocular rosacea |
NCT00348335 ↗ | Efficacy of Topical Cyclosporin for Ocular Rosacea | Completed | Ophthalmic Consultants of Long Island | Phase 4 | 2006-06-01 | The purpose of this study is to determine whether Restasis (topical cyclosporin) is effective in the treatment of ocular rosacea |
NCT00349440 ↗ | Efficacy of Cyclosporine for the Prevention and Treatment of Dry Eye Symptoms Following LASIK or Photorefractive Keratectomy | Completed | Innovative Medical | Phase 4 | 2006-09-01 | The purpose of this study is to evaluate the effect of topical cyclosporine ophthalmic solution 0.05% (Restasis, Allergan) on the signs and symptoms of dry eye in patients undergoing LASIK or photorefractive keratectomy (PRK). |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for restasis
Condition Name
Clinical Trial Locations for restasis
Trials by Country
Clinical Trial Progress for restasis
Clinical Trial Phase
Clinical Trial Sponsors for restasis
Sponsor Name